JP2019528760A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019528760A5 JP2019528760A5 JP2019517047A JP2019517047A JP2019528760A5 JP 2019528760 A5 JP2019528760 A5 JP 2019528760A5 JP 2019517047 A JP2019517047 A JP 2019517047A JP 2019517047 A JP2019517047 A JP 2019517047A JP 2019528760 A5 JP2019528760 A5 JP 2019528760A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- cells
- modified
- population
- unnatural
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2020168576A JP7610948B2 (ja) | 2016-09-30 | 2020-10-05 | 改変された幹細胞メモリーｔ細胞、その作製方法およびその使用方法 |
| JP2021156988A JP2021191312A (ja) | 2016-09-30 | 2021-09-27 | 改変された幹細胞メモリーｔ細胞、その作製方法およびその使用方法 |
| JP2024076779A JP7817312B2 (ja) | 2016-09-30 | 2024-05-09 | 改変された幹細胞メモリーｔ細胞、その作製方法およびその使用方法 |
Applications Claiming Priority (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662402707P | 2016-09-30 | 2016-09-30 | |
| US62/402,707 | 2016-09-30 | ||
| US201762502508P | 2017-05-05 | 2017-05-05 | |
| US62/502,508 | 2017-05-05 | ||
| US201762553058P | 2017-08-31 | 2017-08-31 | |
| US62/553,058 | 2017-08-31 | ||
| US201762556309P | 2017-09-08 | 2017-09-08 | |
| US62/556,309 | 2017-09-08 | ||
| PCT/US2017/054799 WO2018064681A1 (en) | 2016-09-30 | 2017-10-02 | Modified stem cell memory t cells, methods of making and methods of using same |
Related Child Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020168576A Division JP7610948B2 (ja) | 2016-09-30 | 2020-10-05 | 改変された幹細胞メモリーｔ細胞、その作製方法およびその使用方法 |
| JP2021156988A Division JP2021191312A (ja) | 2016-09-30 | 2021-09-27 | 改変された幹細胞メモリーｔ細胞、その作製方法およびその使用方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2019528760A JP2019528760A (ja) | 2019-10-17 |
| JP2019528760A5 true JP2019528760A5 (OSRAM) | 2020-11-12 |
Family
ID=60245180
Family Applications (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019517047A Pending JP2019528760A (ja) | 2016-09-30 | 2017-10-02 | 改変された幹細胞メモリーｔ細胞、その作製方法およびその使用方法 |
| JP2020168576A Active JP7610948B2 (ja) | 2016-09-30 | 2020-10-05 | 改変された幹細胞メモリーｔ細胞、その作製方法およびその使用方法 |
| JP2021156988A Pending JP2021191312A (ja) | 2016-09-30 | 2021-09-27 | 改変された幹細胞メモリーｔ細胞、その作製方法およびその使用方法 |
| JP2024076779A Active JP7817312B2 (ja) | 2016-09-30 | 2024-05-09 | 改変された幹細胞メモリーｔ細胞、その作製方法およびその使用方法 |
Family Applications After (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020168576A Active JP7610948B2 (ja) | 2016-09-30 | 2020-10-05 | 改変された幹細胞メモリーｔ細胞、その作製方法およびその使用方法 |
| JP2021156988A Pending JP2021191312A (ja) | 2016-09-30 | 2021-09-27 | 改変された幹細胞メモリーｔ細胞、その作製方法およびその使用方法 |
| JP2024076779A Active JP7817312B2 (ja) | 2016-09-30 | 2024-05-09 | 改変された幹細胞メモリーｔ細胞、その作製方法およびその使用方法 |
Country Status (9)
| Country | Link |
|---|---|
| EP (1) | EP3519561A1 (OSRAM) |
| JP (4) | JP2019528760A (OSRAM) |
| KR (4) | KR102588469B1 (OSRAM) |
| CN (1) | CN110199015A (OSRAM) |
| AU (4) | AU2017337147A1 (OSRAM) |
| CA (3) | CA3105873A1 (OSRAM) |
| IL (3) | IL287286B (OSRAM) |
| SG (2) | SG10202007963SA (OSRAM) |
| WO (1) | WO2018064681A1 (OSRAM) |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3105873A1 (en) * | 2016-09-30 | 2018-04-05 | Poseida Therapeutics, Inc. | Modified stem cell memory t cells, methods of making and methods of using same |
| US20190119636A1 (en) | 2017-10-23 | 2019-04-25 | Poseida Therapeutics, Inc. | Modified stem cell memory t cells, methods of making and methods of using same |
| KR102523318B1 (ko) | 2016-12-16 | 2023-04-18 | 비-모젠 바이오테크놀로지스, 인크. | 증진된 ｈＡＴ 패밀리 트랜스포존 매개 유전자 전달 및 연관된 조성물, 시스템, 및 방법 |
| US11278570B2 (en) | 2016-12-16 | 2022-03-22 | B-Mogen Biotechnologies, Inc. | Enhanced hAT family transposon-mediated gene transfer and associated compositions, systems, and methods |
| EP3351263A1 (en) | 2017-01-20 | 2018-07-25 | Universitätsklinikum Hamburg-Eppendorf | Pharmaceutical preparation for treating or preventing tissue adhesion |
| ES3008982T3 (en) | 2017-08-18 | 2025-03-25 | Neutrolis Inc | Engineered dnase enzymes and use in therapy |
| WO2019183610A1 (en) * | 2018-03-23 | 2019-09-26 | La Jolla Institute For Allergy And Immunology | Tissue resident memory cell profiles, and uses thereof |
| JP2021527427A (ja) | 2018-06-21 | 2021-10-14 | ビー−モーゲン・バイオテクノロジーズ，インコーポレーテッド | 強化されたｈＡＴファミリーのトランスポゾンが介在する遺伝子導入ならびに関連する組成物、システム、及び方法 |
| US10988746B2 (en) | 2018-10-08 | 2021-04-27 | Neutrolis, Inc. | Manufacturing and engineering of DNASE enzymes for therapy |
| EP3864147A4 (en) | 2018-10-08 | 2022-07-06 | Neutrolis, Inc. | MANIPULATION OF DNASE ENZYMES FOR MANUFACTURE AND THERAPY |
| US11058724B2 (en) * | 2018-10-08 | 2021-07-13 | Neutrolis, Inc. | Methods of using DNASE1-like 3 in therapy |
| US11352613B2 (en) | 2019-02-04 | 2022-06-07 | Neutrolis, Inc. | Engineered human extracellular DNASE enzymes |
| EP3923992A1 (en) | 2019-02-15 | 2021-12-22 | CRISPR Therapeutics AG | Gene editing for hemophilia a with improved factor viii expression |
| BR112021021349A2 (pt) * | 2019-04-26 | 2022-02-01 | Allogene Therapeutics Inc | Métodos de fabricação de células car t alogênicas |
| CN113710284A (zh) * | 2019-06-05 | 2021-11-26 | 克里斯珀医疗股份公司 | 具有改善的因子viii表达的血友病a基因编辑 |
| CN110358734B (zh) * | 2019-06-13 | 2020-08-25 | 首都医科大学宣武医院 | 以Tcm为主要效应成分的CAR-T制备方法及其应用 |
| AU2020403155A1 (en) * | 2019-12-11 | 2022-06-30 | Myeloid Therapeutics, Inc. | Therapeutic cell compositions and methods for manufacture and uses thereof |
| CA3171369A1 (en) * | 2020-02-28 | 2021-09-02 | Wisconsin Alumni Research Foundation | Nonviral generation of genome edited chimeric antigen receptor t cells |
| CA3170493A1 (en) | 2020-03-13 | 2021-09-16 | Stephen John GOULD | Exosomal nucleic acid vaccine modularly configured to harness multiple antigen presentation mechanisms |
| US12365871B2 (en) | 2020-04-28 | 2025-07-22 | Lyell Immunopharma, Inc. | Methods for culturing cells |
| US20240060090A1 (en) * | 2021-02-23 | 2024-02-22 | Poseida Therapeutics, Inc. | Genetically modified induced pluripotent stem cells and methods of use thereof |
| CN114990061B (zh) * | 2022-06-30 | 2023-08-29 | 河南省人民医院 | 一种诱导扩增中央记忆性t细胞的培养方法 |
| CN116444666A (zh) * | 2023-05-22 | 2023-07-18 | 上海交通大学医学院附属仁济医院 | Cdh17特异性诊疗一体化分子影像探针的制备方法及应用 |
| WO2025221789A1 (en) | 2024-04-16 | 2025-10-23 | Poseida Therapeutics, Inc. | Compositions and methods for use in car/tcr cell therapies |
| CN118272305B (zh) * | 2024-04-29 | 2025-04-08 | 深圳泽医细胞治疗集团有限公司 | 一种免疫细胞的培养基及其应用 |
| WO2026080393A1 (en) | 2024-10-07 | 2026-04-16 | Poseida Therapeutics, Inc. | Compositions and methods for use in car cell therapies |
Family Cites Families (35)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4554101A (en) | 1981-01-09 | 1985-11-19 | New York Blood Center, Inc. | Identification and preparation of epitopes on antigens and allergens on the basis of hydrophilicity |
| US5168062A (en) | 1985-01-30 | 1992-12-01 | University Of Iowa Research Foundation | Transfer vectors and microorganisms containing human cytomegalovirus immediate-early promoter-regulatory DNA sequence |
| GB8601597D0 (en) | 1986-01-23 | 1986-02-26 | Wilson R H | Nucleotide sequences |
| US5266491A (en) | 1989-03-14 | 1993-11-30 | Mochida Pharmaceutical Co., Ltd. | DNA fragment and expression plasmid containing the DNA fragment |
| US5580734A (en) | 1990-07-13 | 1996-12-03 | Transkaryotic Therapies, Inc. | Method of producing a physical map contigous DNA sequences |
| US5968502A (en) | 1991-11-05 | 1999-10-19 | Transkaryotic Therapies, Inc. | Protein production and protein delivery |
| US5641670A (en) | 1991-11-05 | 1997-06-24 | Transkaryotic Therapies, Inc. | Protein production and protein delivery |
| WO1995030413A1 (en) * | 1994-05-10 | 1995-11-16 | The Kitasato Institute | Hematopoietic stem cell proliferation accelerator |
| US6218185B1 (en) | 1996-04-19 | 2001-04-17 | The United States Of America As Represented By The Secretary Of Agriculture | Piggybac transposon-based genetic transformation system for insects |
| US6835394B1 (en) | 1999-12-14 | 2004-12-28 | The Trustees Of The University Of Pennsylvania | Polymersomes and related encapsulating membranes |
| US6962810B2 (en) | 2000-10-31 | 2005-11-08 | University Of Notre Dame Du Lac | Methods and compositions for transposition using minimal segments of the eukaryotic transformation vector piggyBac |
| US7105343B1 (en) | 2000-10-31 | 2006-09-12 | University Of Notre Dame Du Lac | Methods and compositions for transposition using minimal segments of the eukaryotic transformation vector Piggybac |
| IL152904A0 (en) * | 2002-01-24 | 2003-06-24 | Gamida Cell Ltd | Utilization of retinoid and vitamin d receptor antagonists for expansion of renewable stem cell populations |
| WO2004016731A2 (en) * | 2002-08-19 | 2004-02-26 | Gamida-Cell Ltd. | Ex-vivo expansion of hematopoietic stem cell populations in mononuclear cell cultures |
| EP2401367B1 (en) * | 2009-02-26 | 2016-11-30 | Transposagen Biopharmaceuticals, Inc. | Hyperactive piggybac transposases |
| EP2439997B1 (en) * | 2009-06-02 | 2019-08-28 | Sun Patent Trust | Wireless communication apparatus and wireless communication method |
| US8808748B2 (en) | 2010-04-20 | 2014-08-19 | Vindico NanoBio Technology Inc. | Biodegradable nanoparticles as novel hemoglobin-based oxygen carriers and methods of using the same |
| ES2718308T3 (es) | 2011-01-07 | 2019-07-01 | Poseida Therapeutics Inc | Composiciones y métodos para la administración a tumores de agentes de unión de alta afinidad al oxígeno |
| ES2709216T3 (es) * | 2011-06-07 | 2019-04-15 | Helmholtz Zentrum Muenchen Deutsches Forschungszentrum Gesundheit & Umwelt Gmbh | Proteínas que tienen actividad nucleasa, proteínas de fusión y usos de estas |
| EP3594245A1 (en) * | 2012-02-13 | 2020-01-15 | Seattle Children's Hospital d/b/a Seattle Children's Research Institute | Bispecific chimeric antigen receptors and therapeutic uses thereof |
| US10378027B2 (en) * | 2013-03-15 | 2019-08-13 | The General Hospital Corporation | RNA-guided targeting of genetic and epigenomic regulatory proteins to specific genomic loci |
| EP2975942B1 (en) * | 2013-03-21 | 2018-08-08 | Sangamo Therapeutics, Inc. | Targeted disruption of t cell receptor genes using engineered zinc finger protein nucleases |
| EP3974520A1 (en) * | 2013-05-14 | 2022-03-30 | Board of Regents, The University of Texas System | Human application of engineered chimeric antigen receptor (car) t-cells |
| EP3593812A3 (en) * | 2014-03-15 | 2020-05-27 | Novartis AG | Treatment of cancer using chimeric antigen receptor |
| WO2015157579A2 (en) * | 2014-04-09 | 2015-10-15 | Dna2.0, Inc. | Enhanced nucleic acid constructs for eukaryotic gene expression |
| AU2015289644A1 (en) * | 2014-07-15 | 2017-02-02 | Juno Therapeutics, Inc. | Engineered cells for adoptive cell therapy |
| CA2957552C (en) | 2014-08-08 | 2024-01-16 | Vindico Nanobiotechnology, Llc | Compositions and methods for inducing nanoparticle-mediated microvascular embolization of tumors |
| ES2808914T3 (es) * | 2014-09-04 | 2021-03-02 | Stemcell Tech Inc | Complejos de anticuerpo solubles para la activación y expansión de linfocitos T o células NK |
| EP3018200A1 (en) * | 2014-11-07 | 2016-05-11 | Fondazione Matilde Tettamanti e Menotti de Machi Onlus | Improved method for the generation of genetically modified cells |
| CA2969684A1 (en) | 2014-12-05 | 2016-06-09 | Vindico Nanobiotechnology, Llc | Compositions and methods for inducing nanoparticle-mediated microvascular embolization of tumors |
| CN107567461A (zh) * | 2014-12-29 | 2018-01-09 | 诺华股份有限公司 | 制备嵌合抗原受体表达细胞的方法 |
| ES2886599T3 (es) * | 2015-06-17 | 2021-12-20 | Poseida Therapeutics Inc | Composiciones y métodos para dirigir proteínas a loci específicos en el genoma |
| US20170000743A1 (en) | 2015-07-02 | 2017-01-05 | Vindico NanoBio Technology Inc. | Compositions and Methods for Delivery of Gene Editing Tools Using Polymeric Vesicles |
| US10456452B2 (en) | 2015-07-02 | 2019-10-29 | Poseida Therapeutics, Inc. | Compositions and methods for improved encapsulation of functional proteins in polymeric vesicles |
| CA3105873A1 (en) * | 2016-09-30 | 2018-04-05 | Poseida Therapeutics, Inc. | Modified stem cell memory t cells, methods of making and methods of using same |
-
2017
- 2017-10-02 CA CA3105873A patent/CA3105873A1/en not_active Abandoned
- 2017-10-02 KR KR1020207026327A patent/KR102588469B1/ko active Active
- 2017-10-02 KR KR1020257001336A patent/KR20250011252A/ko active Pending
- 2017-10-02 CN CN201780073874.1A patent/CN110199015A/zh active Pending
- 2017-10-02 SG SG10202007963SA patent/SG10202007963SA/en unknown
- 2017-10-02 KR KR1020237007633A patent/KR102757155B1/ko active Active
- 2017-10-02 JP JP2019517047A patent/JP2019528760A/ja active Pending
- 2017-10-02 AU AU2017337147A patent/AU2017337147A1/en not_active Abandoned
- 2017-10-02 CA CA3036926A patent/CA3036926C/en active Active
- 2017-10-02 EP EP17794119.2A patent/EP3519561A1/en active Pending
- 2017-10-02 CA CA3154236A patent/CA3154236C/en active Active
- 2017-10-02 IL IL287286A patent/IL287286B/en unknown
- 2017-10-02 WO PCT/US2017/054799 patent/WO2018064681A1/en not_active Ceased
- 2017-10-02 SG SG11201901959YA patent/SG11201901959YA/en unknown
- 2017-10-02 KR KR1020197011671A patent/KR20190063468A/ko not_active Ceased
-
2019
- 2019-03-04 IL IL265157A patent/IL265157B/en active IP Right Grant
-
2020
- 2020-08-25 IL IL276907A patent/IL276907B/en unknown
- 2020-09-01 AU AU2020227020A patent/AU2020227020B2/en active Active
- 2020-10-05 JP JP2020168576A patent/JP7610948B2/ja active Active
-
2021
- 2021-09-27 JP JP2021156988A patent/JP2021191312A/ja active Pending
-
2022
- 2022-09-23 AU AU2022235633A patent/AU2022235633B2/en active Active
-
2024
- 2024-05-09 JP JP2024076779A patent/JP7817312B2/ja active Active
-
2025
- 2025-04-29 AU AU2025203005A patent/AU2025203005A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP4427809A3 (en) | Altering gene expression in car-t cells and uses thereof | |
| JP2013176400A5 (OSRAM) | ||
| IL287286B (en) | Differentiated stem cell memory t cells, methods for their preparation and methods for using them | |
| MX395574B (es) | Metodo y composiciones para inmunoterapia celular. | |
| JP2013501505A5 (OSRAM) | ||
| EA201891212A1 (ru) | Адресная дезорганизация клеточного рецептора гкгс | |
| MX2018014941A (es) | Anticuerpo para unirse al receptor de interleucina 4. | |
| JP2017512484A5 (OSRAM) | ||
| EA201890772A1 (ru) | Способ высокоуровневого и стабильного переноса генов в лимфоцитах | |
| HK1216894A1 (zh) | 多價結合蛋白組合物 | |
| NZ705675A (en) | Engineered transgene integration platform (etip) for gene targeting and trait stacking | |
| JP2016500260A5 (OSRAM) | ||
| EP4218409A3 (en) | Mice expressing a limited immunoglobulin light chain repertoire | |
| CY1123348T1 (el) | Μεθοδος για την παρασκευη ενισχυμενων πολυδυναμων βλαστοκυτταρων απο μεσεγχυματικα βλαστοκυτταρα με τη χρηση κλασματος φλοροταννινης | |
| JP2019534684A5 (OSRAM) | ||
| EP3587560A4 (en) | Endodermal cell mass, and method for producing any one of three primary germ layer cell mass from pluripotent cells | |
| Sikorskaya | Noosferic aspects of networked collaborations among vocational educational institutions in Russia | |
| PL415351A1 (pl) | Sposób namnażania in vitro komórek T regulatorowych (Treg) | |
| JP2013503602A5 (OSRAM) | ||
| JP2014533495A5 (OSRAM) | ||
| Kornienko | PRINCIPLES OF FORMING OF SYSTEM OF ECONOMIC ANALYSIS ARE IN MANAGEMENT ENTERPRISE | |
| Phuc et al. | Visualization of the Epiblast and Visceral Endodermal Cells Using Fgf5-P2A-Venus BAC Transgenic Mice and Epiblast Stem Cells | |
| Metelitsa | AN ANALYSIS OF DIFFICULTIES READING ACADEMIC ARTCILES OF STUDENTS OF TECHNICAL SPECIALISATIONS AND ATTEMPTS TO SOLVE THEM | |
| Konishchev et al. | EARTH'S CRYOSPHERE | |
| Pavlova et al. | PREPARATORY PROCESS FOR PUPILS TO THE OLYMPIADS IN INFORMATICS |